Eisenhut Michael, Thorburn Kentigern, Ahmed Tageldin
Paediatric Intensive Care Unit, Royal Liverpool Children's NHS Trust Alder Hey, Eaton Road, Liverpool L12 2AP, UK.
Intensive Care Med. 2004 May;30(5):931-4. doi: 10.1007/s00134-004-2236-2. Epub 2004 Mar 13.
To compare disease severity as judged by duration of ventilation, inotrope use and mortality in children ventilated for respiratory syncytial virus (RSV)-positive lower respiratory tract infection (LRTI) with and without elevated transaminase levels and to determine the aetiology of elevated transaminase levels in this patient group.
Prospective observational study.
Twenty-two-bed Paediatric Intensive Care Unit.
Forty-eight ventilated children with RSV-positive LRTI.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured daily. In patients with elevated transaminase levels infection with the following viruses was investigated: hepatitis A, B and C viruses, cytomegalovirus, Epstein Barr virus, adenovirus, influenza virus, and parainfluenza viruses (types I, II, and III). Elevated transaminase levels were detected in 22 (46%) patients. The duration of mechanical ventilation (geometric mean; 95% CI) was significantly ( P<0.05) longer in the group with elevated transaminase levels: 10.6 (9.4; 11.7) days versus 3.5 (2.8; 4.2) days. This difference remained significant in patients without congenital heart disease. Inotrope use was more common and all deaths occurred in the group with elevated transaminase levels ( P<0.05). All patients who died and all but two patients with inotrope requirements had underlying congenital heart disease. One patient with elevated transaminase levels had a simultaneous infection with influenza A virus.
RSV disease in ventilated children was more severe if transaminase levels were elevated. Transaminase level elevation was due to hepatitis in the majority of patients. In patients with congenital heart disease we also detected myocardial involvement.
比较因呼吸道合胞病毒(RSV)阳性下呼吸道感染(LRTI)而接受通气治疗的儿童,在转氨酶水平升高和未升高的情况下,通过通气时间、使用血管活性药物情况及死亡率判断的疾病严重程度,并确定该患者群体转氨酶水平升高的病因。
前瞻性观察研究。
拥有22张床位的儿科重症监护病房。
48名因RSV阳性LRTI而接受通气治疗的儿童。
每天测量丙氨酸转氨酶(ALT)和天冬氨酸转氨酶(AST)水平。对转氨酶水平升高的患者进行以下病毒感染情况调查:甲型、乙型和丙型肝炎病毒、巨细胞病毒、爱泼斯坦-巴尔病毒、腺病毒、流感病毒和副流感病毒(I、II和III型)。22名(46%)患者检测到转氨酶水平升高。转氨酶水平升高组的机械通气时间(几何平均数;95%可信区间)显著更长(P<0.05):10.6(9.4;11.7)天对3.5(2.8;4.2)天。在无先天性心脏病的患者中,这种差异仍然显著。血管活性药物的使用更为常见,且所有死亡病例均发生在转氨酶水平升高组(P<0.05)。所有死亡患者以及除两名需要使用血管活性药物的患者外,其余患者均患有先天性心脏病。一名转氨酶水平升高的患者同时感染了甲型流感病毒。
通气治疗的儿童若转氨酶水平升高,RSV疾病更为严重。大多数患者转氨酶水平升高是由肝炎所致。在先天性心脏病患者中,我们还检测到心肌受累情况。